Good News! The Joint Application Project of Military Medical Research Institute and Sungen Biomedical Won the First Prize
At 9:00 AM on November 19, the "City Science and Technology Conference / Science and Technology Award Conference" was held in the lecture hall of the Beijing Convention Center. Sponsored by ...
Research Progress of SGC001, The World's First Myocardial Infarction Antibody Drug
On November 16, 2024, the "The first China Pharmaceutical Valley • Future Biological Innovative Drugs Conference" was successfully held in Beijing, which was sponsored by the Management Com...
Focusing on the Frontier Trends: The First China Pharmaceutical Valley • Future Biological Innovative Drugs Conference
From November 15th to 16th, "The First China Pharmaceutical Valley · Future Biological Innovative Drug Conference" was held in Beijing. The conference focused on the hot topics of "bio...
Molecular Discovery Platform
A molecular discovery platform leverages advanced technologies like synthetic libraries, hybridoma, Bispecific Antibody, single B cell sorting, and AI to identify and develop novel antibodies efficiently.
The First China Pharmaceutical Valley • Future Biological Innovative Drugs Conference was successfully held
From November 15 to 16, 2024, the highly anticipated "The first China Pharmaceutical Valley • Future Biological Innovative Drugs Conference" was successfully held in Daxing, Beijing. It was...
Pilot R & D and Production Platform
Our pilot R&D and production platform excels in small-scale processes and Fed-Batch culture, using advanced purification technologies like affinity and ion exchange chromatography. We produce high-purity antibody and protein solutions, and various drug products with industry-leading filling accuracy.
Techniques for the Preparation of Human Monoclonal Antibodies
Antibody StructureImmunoglobulins (Ig) or antibodies are important components of the immune system. They can specifically bind antigens through antigen-binding fragment(Fab) sites and activate other c...
Technological Platforms
Sungen Core Technologies
Sungen Biomedical Won the First Prize of Beijing Science and Technology Progress Award, Demonstrating Great Scientific Research Capacity
In April 2024, the Beijing Municipal People s Government issued the Decision on the Beijing Municipal Science and Technology Award in 2023. The project of Construction of a transformation sy...
Quality Control Platform
A quality control platform conducts comprehensive tests including molecular weight, sequence coverage, disulfide bond location, peptide mapping, N/C terminal sequencing, post-translational modifications, DAR value, and unknown peak identification.
From Acceleration of FIC Antibodies Research by AI to Exploration of New Quality Productivity in the Biomedical Industry
New quality productivity is a new concept first proposed by JinPing Xi during his investigation in Heilongjiang in September 2023, emphasizing that "integrating scientific and technological innov...
Co-operation to Create a New Chapter in the Research and Development of Biological Innovative Drugs for Cardiovascular Diseases
On November 20, 2023, Mr. Lin Changqing, Chairman and president of Beijing Hotgen Biotech Co., Ltd., Professor Du Jie, President of Beijing Antai Institute of Cardiovascular Medicine, and Professor Su...
The Official Opening Ceremony of the 'National Human Brain Health Project' Joint Laboratory was Held in Beijing
On October 31, 2023, the opening ceremony of the "National Human Brain Health Project" joint laboratory was initiated by Beijing Hotgen Biotech Co., LTD. ( "Hotgen Biotech"), Shenz...
Sungen Biomedical and Taizhou People's Hospital Officially Signed a Contract for Integration and Development
On January 3, 2024, Taizhou People's Hospital Affiliated to Nanjing Medical University held a conference on "Integrated Development of Hospital and Enterprise - Innovation and Transformation&...
